Skip to main content
Sign In
 

April W. Armstrong, MD MPH


Dr. April Armstrong
Vice Chair of Clinical Research
Associate Professor of Dermatology
Director, Clinical Trials and Outcomes Research
Director, Psoriasis Program
 
Dr. April Armstrong is Vice Chair of Clinical Research, Director of Clinical Trials and Outcomes Research, and Director of the Psoriasis Program at Department of Dermatology, University of Colorado School of Medicine. Dr. Armstrong has expertise in outcomes research, psoriasis, and technology-enabled delivery of healthcare. She obtained Doctor of Medicine (M.D.) from Harvard Medical School and completed dermatology residency at Harvard Dermatology Residency Program. Dr. Armstrong also obtained a Master of Public Health degree from Harvard School of Public Health. Prior to joining CU, Dr. Armstrong served as Vice Chair of Clinical Research as well as Director of Clinical Research Unit, Teledermatology, and the Psoriasis Clinic at University of California Davis. She has authored over 130 peer-reviewed scientific publications and has been an editor for the top pharmacology textbook Principles of Pharmacology.
 
Dr. Armstrong believes that good clinical practice needs to be rooted in evidence-based medicine. Dr. Armstrong is skilled in all aspects of general dermatology, including inflammatory skin diseases and skin cancers. Dr. Armstrong’s clinical expertise lies in psoriasis. She is dedicated to providing the highest quality of care for psoriasis patients and making available to them the latest treatment options. Dr. Armstrong regularly receives referrals from colleagues for patients with severe psoriasis and enjoys caring for these patients.
 
Dr. Dr. Armstrong is also recognized internationally for her efforts in telehealth. She utilizes telehealth technology to provide dermatology consultations to remote communities and underserved populations. Prior to moving to Colorado, Dr. Armstrong cared for underserved patients from all corners of California through real-time, videoconferencing teledermatology and store-and-forward teledermatology.
 
Dr. Armstrong holds multiple leadership positions at professional societies, including serving as Vice Chair for Teledermatology SIG at the American Telemedicine Association, Medical Board Member of the National Psoriasis Foundation, Steering Committee Member for Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, and Task Force and Committee Member for multiple committees at the American Academy of Dermatology. Dr. Armstrong also serves on the editorial boards of JAMA Dermatology, Journal of the American Academy of Dermatology, and Telemedicine and eHealth. She was also past President of Sacramento Valley Dermatologic Society.
 
Undergraduate Education: Lewis & Clark College, Portland, Oregon, Biochemistry and Communication, B.A. with honors
Medical Education: Harvard Medical School, Boston, Massachusetts, M.D.
Internship: Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, Internal Medicine
Residency: Harvard Dermatology Residency Program, Boston, Massachusetts
Post-Graduate Education: Harvard School of Public Health, Boston, Massachusetts, Master of Public Health
Board Certification: American Board of Dermatology
 
RESEARCH BIO
 
Dr. Armstrong is committed to advancing departmental efforts in patient-oriented research, including investigator-initiated research and clinical trials. She also serves as a liaison between the department and Colorado Health Outcomes Program (COHO) and the Colorado Clinical and Translational Sciences Institute (CCTSI).
 
Dr. Armstrong’s research focus lies in health outcomes, epidemiology, and technology-enabled models of healthcare delivery. She is particularly interested in psoriasis comorbidities, the appropriate use of biologic agents, and comparative effectiveness research. Dr. Armstrong has conducted studies examining how new therapies impact patients’ disease states, quality of life, and their access to medical care. Furthermore, she has examined how novel telehealth models of healthcare delivery may increase patient access to specialty care and improve clinical outcomes. She also has extensive clinical trial experience, having led or collaborated on over 120 study protocols. Dr. Armstrong is also affiliated with the Colorado Health Outcomes Program (COHO) and collaborates regularly with COHO investigators.
 
Dr. Armstrong is a federally funded investigator. She was awarded research funding from multiple federal agencies and foundations, including the Agency for Healthcare Research and Quality, NIH, Dermatology Foundation, National Psoriasis Foundation, and Women's Dermatologic Society. Dr. Armstrong was selected to receive multiple career development awards from the Dermatology Foundation, NIH CTSC K12 Mentored Career Development Award, and AHRQ K08 Career Development Award.
 
Dr. Armstrong is also dedicated to the educational and research goals of dermatology trainees, having mentored numerous medical students, fellows, and residents. She has worked with many high-caliber trainees over the years and has received faculty awards for mentoring research trainees. Many of her former trainees have matched to top dermatology residency programs and embarked on successful dermatology careers. For medical students, physicians, and other trainees (MPH and PhD trainees) interested in long-term or short-term clinical research opportunities on Dr. Armstrong’s team, please send a CV and a brief cover letter to Mr. Chase Cameron at chase.cameron@ucdenver.edu

For CU medical students interested in doing a research elective with Dr. Armstrong, arrangements can be made for a credited research elective (DERM 8600) for 4 weeks or 8 weeks. For medical students from outside of University of Colorado, arrangements can also be made for research electives greater than 4 weeks. Please contact Chase for more information, chase.cameron@ucdenver.edu
 
Professional Memberships:
Dermatology Foundation
Society of Investigative Dermatology

National Psoriasis Foundation
International Psoriasis Council (IPC)
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
American Academy of Dermatology

American Telemedicine Association

 
PUBLICATIONS:
Please click here for up-to-date publications by Dr. Armstrong’s research team.
 
Selected Publications: 
 
Armstrong AW, Robertson AD, Wu J, Schupp C, Lebwohl MG. Under-treatment,Treatment Trends, and Treatment Dissatisfaction Among Patients With Psoriasis and Psoriatic Arthritis in the United States: Findings From the National Psoriasis Foundation Surveys, 2003-2011. JAMA Dermatology. Oct 1;149(10):1180-5.
 
Bhutani T, Wong JW, Bebo BF, Armstrong AW. Access to health care in patients with psoriasis and psoriatic arthritis: data from national psoriasis foundation survey panels. JAMA Dermatology. 2013 Jun 1;149(6):717-21.
 
Armstrong EJ, Harskamp CT, Armstrong AW. Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc. 2013 Apr 4;2(2). PubMed PMID: 23557749.
 
Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatol. 2013 Jan;149(1):84-91.
 
Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013 Apr;68(4):654-62.
 
Armstrong AW, Schupp C, Wu J, Bebo B. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003-2011. PLoS One. 2012;7(12):e52935.
 
Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens. 2012 Dec 15. [Epub ahead of print]
 
Foolad N, Brezinski EA, Chase EP, Armstrong AW. Effect of Nutrient Supplementation on Atopic Dermatitis in Children: A Systematic Review of Probiotics, Prebiotics, Formula, and Fatty Acids. Arch Dermatol. 2012 Dec 17:1-6.
 
Armstrong AW, Follansbee MR, Harskamp CT, Schupp CW. Psoriasis and sexual behavior in U.S. women: an epidemiologic analysis using the National Health and Nutrition Examination Survey (NHANES). J Sex Med. 2013 Feb;10(2):326-32.
 
Armstrong AW, Schupp C, Bebo B. Psoriasis comorbidities: results from the National Psoriasis Foundation surveys 2003 to 2011. Dermatology. 2012;225(2):121-6.
 
Armstrong AW, Harskamp CT, Cheeney S, Wu J, Schupp CW. Power of crowdsourcing: novel methods of data collection in psoriasis and psoriatic arthritis. J Am Acad Dermatol. 2012 Dec;67(6):1273-1281.
 
Armstrong AW, Wu J, Kovarik CL, Goldyne ME, Oh DH, McKoy KC, Shippy AM, Pak HS. State of teledermatology programs in the United States. J Am Acad Dermatol. 2012 Nov;67(5):939-44.
 
Lamel S, Chambers CJ, Ratnarathorn M, Armstrong AW. Impact of live interactive teledermatology on diagnosis, disease management, and clinical outcomes. Arch Dermatol. 2012 Jan;148(1):61-5.
 
Armstrong AW, Harskamp CT, Ledo L, Rogers JH, Armstrong EJ. Coronary artery disease in patients with psoriasis referred for coronary angiography. Am J Cardiol. 2012 Apr 1;109(7):976-80.
 
Chambers CJ, Parsi KK, Schupp C, Armstrong AW. Patient-centered online management of psoriasis: a randomized controlled equivalency trial. J Am Acad Dermatol. 2012 Jun;66(6):948-53.
 
Armstrong AW, Lin SW, Chambers CJ, Sockolov ME, Chin DL. Psoriasis and hypertension severity: results from a case-control study. PLoS One. 2011 Mar 29;6(3).
 
Armstrong AW, Watson AJ, Kazanis M, Frangos JE, Kimball AB, Kvedar JC. Text-Message Reminders Improve Sunscreen Use: A Randomized, Controlled Trial Using Electronic Monitoring. Arch Derm, Arch Dermatol. 2009 Nov;145 (11): 1230-6.
 
Selected Book Publications
 
Golan DE, Tashjian AH, Armstrong EJ, Armstrong AW Eds. Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy, 1st, 2nd, and 3rd editions. Lippincott Williams & Wilkins, Baltimore, MD.